Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
4.230
+0.150 (3.68%)
At close: Dec 20, 2024, 4:00 PM
4.220
-0.010 (-0.24%)
After-hours: Dec 20, 2024, 7:59 PM EST
Biomea Fusion Employees
Biomea Fusion had 103 employees as of December 31, 2023. The number of employees increased by 20 or 24.10% compared to the previous year.
Employees
103
Change (1Y)
20
Growth (1Y)
24.10%
Revenue / Employee
n/a
Profits / Employee
-$1,398,136
Market Cap
153.29M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 103 | 20 | 24.10% |
| Dec 31, 2022 | 83 | 32 | 62.75% |
| Dec 31, 2021 | 51 | 39 | 325.00% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nevro | 1,215 |
| The Joint | 794 |
| Adaptimmune Therapeutics | 449 |
| Sutro Biopharma | 302 |
| Metagenomi | 236 |
| Cellectis | 221 |
| Vaxart | 109 |
| Aligos Therapeutics | 66 |
BMEA News
- 4 days ago - Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday? - Benzinga
- 4 days ago - Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes - GlobeNewsWire
- 5 days ago - Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D) - GlobeNewsWire
- 9 days ago - Biomea Fusion Announces Oral and Poster Presentations of Icovamenib at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) - GlobeNewsWire
- 12 days ago - Biomea Fusion Announces Preliminary Data from Ongoing COVALENT-103 Study of Investigational Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia - GlobeNewsWire
- 15 days ago - Biomea Fusion to Host Conference Call to Present initial Clinical Data from Phase I COVALENT-103 Study of BMF-500, a Covalent FLT3 Inhibitor, in Relapsed or Refractory Acute Leukemia - GlobeNewsWire
- 19 days ago - Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Biomea Fusion, Inc. For Securities Law Violations - Accesswire